US Stock MarketDetailed Quotes

LIXT Lixte Biotechnology

Watchlist
  • 1.6300
  • +0.1100+7.24%
Close Nov 22 16:00 ET
3.67MMarket Cap-942P/E (TTM)

Lixte Biotechnology Key Stats

Earnings

Revenue Breakdown

Financial Indicators

Income Statement

Balance Sheet

Cash Flow

Quarterly+Annual
YOY yoy
Hide blank lines yoy
(Q3)Sep 30, 2024
(Q2)Jun 30, 2024
(Q1)Mar 31, 2024
(FY)Dec 31, 2023
(Q4)Dec 31, 2023
(Q3)Sep 30, 2023
(Q2)Jun 30, 2023
(Q1)Mar 31, 2023
(FY)Dec 31, 2022
(Q4)Dec 31, 2022
Assets
Current assets
Cash, cash equivalents and short term investments
-67.92%1.64M
-10.91%2.6M
-16.49%3.41M
-21.48%4.2M
-21.48%4.2M
-22.19%5.11M
-62.34%2.91M
8.22%4.09M
10.98%5.35M
10.98%5.35M
-Cash and cash equivalents
-67.92%1.64M
-10.91%2.6M
-16.49%3.41M
-21.48%4.2M
-21.48%4.2M
-22.19%5.11M
-62.34%2.91M
8.22%4.09M
10.98%5.35M
10.98%5.35M
Prepaid assets
-49.29%51.34K
-45.44%72.38K
-6.15%174.94K
-49.36%105.13K
-49.36%105.13K
-56.67%101.25K
-46.39%132.67K
-32.73%186.41K
-19.93%207.59K
-19.93%207.59K
Other current assets
----
----
----
----
----
16.21%27.84K
22.19%49.56K
8.05%56.1K
----
----
Total current assets
-67.74%1.69M
-13.81%2.67M
-17.12%3.59M
-22.52%4.31M
-22.52%4.31M
-23.24%5.23M
-61.43%3.1M
5.46%4.33M
9.18%5.56M
9.18%5.56M
Non current assets
Non current deferred assets
--6.93K
----
----
----
----
----
----
----
----
----
Total non current assets
--6.93K
--0
--0
--0
--0
--0
--0
--0
--0
--0
Total assets
-67.60%1.7M
-13.81%2.67M
-17.12%3.59M
-22.52%4.31M
-22.52%4.31M
-23.24%5.23M
-61.43%3.1M
5.18%4.33M
9.18%5.56M
9.18%5.56M
Liabilities
Current liabilities
Payables
----
----
----
-32.06%156.76K
-32.06%156.76K
----
----
----
--230.73K
--230.73K
-accounts payable
----
----
----
-34.42%120.51K
-34.42%120.51K
----
----
----
--183.75K
--183.75K
-Due to related parties current
----
----
----
-22.84%36.25K
-22.84%36.25K
----
----
----
--46.98K
--46.98K
Current deferred liabilities
182.78%256.1K
703.80%290.06K
720.11%216.15K
-4.80%157.1K
-4.80%157.1K
-10.27%90.57K
-77.28%36.09K
-90.42%26.36K
114.42%165.02K
114.42%165.02K
Current liabilities
5.52%328.96K
4.68%421.47K
85.14%462.84K
-20.69%313.86K
-20.69%313.86K
-23.66%311.74K
-24.26%402.61K
-61.22%249.99K
30.64%395.76K
30.64%395.76K
Non current liabilities
Total non current liabilities
--0
--0
--0
--0
--0
--0
--0
--0
--0
--0
Total liabilities
5.52%328.96K
4.68%421.47K
85.14%462.84K
-20.69%313.86K
-20.69%313.86K
-23.66%311.74K
-24.26%402.61K
-61.22%249.99K
30.64%395.76K
30.64%395.76K
Shareholders'equity
Share capital
0.00%3.5M
0.00%3.5M
-0.04%3.5M
0.00%3.5M
0.00%3.5M
-0.04%3.5M
-0.04%3.5M
0.01%3.5M
-0.03%3.5M
-0.03%3.5M
-common stock
0.00%225
35.54%225
-86.49%225
35.54%225
35.54%225
-86.48%225
-90.02%166
21.18%1.67K
-87.92%166
-87.92%166
-Preferred stock
0.00%3.5M
0.00%3.5M
0.00%3.5M
0.00%3.5M
0.00%3.5M
0.00%3.5M
0.00%3.5M
0.00%3.5M
0.00%3.5M
0.00%3.5M
Retained earnings
-8.43%-51.45M
-8.69%-50.46M
-10.48%-49.45M
-11.72%-48.48M
-11.72%-48.48M
-13.61%-47.45M
-15.25%-46.43M
-15.55%-44.76M
-17.02%-43.39M
-17.02%-43.39M
Paid-in capital
0.91%49.32M
7.86%49.21M
8.24%49.08M
8.69%48.98M
8.69%48.98M
9.40%48.87M
3.04%45.62M
17.13%45.34M
17.43%45.06M
17.43%45.06M
Total stockholders'equity
-72.23%1.37M
-16.58%2.25M
-23.39%3.13M
-22.66%3.99M
-22.66%3.99M
-23.21%4.92M
-64.06%2.69M
17.50%4.08M
7.83%5.17M
7.83%5.17M
Total equity
-72.23%1.37M
-16.58%2.25M
-23.39%3.13M
-22.66%3.99M
-22.66%3.99M
-23.21%4.92M
-64.06%2.69M
17.50%4.08M
7.83%5.17M
7.83%5.17M
Currency Unit
USD
USD
USD
USD
USD
USD
USD
USD
USD
USD
Audit Opinions
--
--
--
Unqualified Opinion with Explanatory Notes
--
--
--
--
Unqualified Opinion with Explanatory Notes
--
(Q3)Sep 30, 2024(Q2)Jun 30, 2024(Q1)Mar 31, 2024(FY)Dec 31, 2023(Q4)Dec 31, 2023(Q3)Sep 30, 2023(Q2)Jun 30, 2023(Q1)Mar 31, 2023(FY)Dec 31, 2022(Q4)Dec 31, 2022
Assets
Current assets
Cash, cash equivalents and short term investments -67.92%1.64M-10.91%2.6M-16.49%3.41M-21.48%4.2M-21.48%4.2M-22.19%5.11M-62.34%2.91M8.22%4.09M10.98%5.35M10.98%5.35M
-Cash and cash equivalents -67.92%1.64M-10.91%2.6M-16.49%3.41M-21.48%4.2M-21.48%4.2M-22.19%5.11M-62.34%2.91M8.22%4.09M10.98%5.35M10.98%5.35M
Prepaid assets -49.29%51.34K-45.44%72.38K-6.15%174.94K-49.36%105.13K-49.36%105.13K-56.67%101.25K-46.39%132.67K-32.73%186.41K-19.93%207.59K-19.93%207.59K
Other current assets --------------------16.21%27.84K22.19%49.56K8.05%56.1K--------
Total current assets -67.74%1.69M-13.81%2.67M-17.12%3.59M-22.52%4.31M-22.52%4.31M-23.24%5.23M-61.43%3.1M5.46%4.33M9.18%5.56M9.18%5.56M
Non current assets
Non current deferred assets --6.93K------------------------------------
Total non current assets --6.93K--0--0--0--0--0--0--0--0--0
Total assets -67.60%1.7M-13.81%2.67M-17.12%3.59M-22.52%4.31M-22.52%4.31M-23.24%5.23M-61.43%3.1M5.18%4.33M9.18%5.56M9.18%5.56M
Liabilities
Current liabilities
Payables -------------32.06%156.76K-32.06%156.76K--------------230.73K--230.73K
-accounts payable -------------34.42%120.51K-34.42%120.51K--------------183.75K--183.75K
-Due to related parties current -------------22.84%36.25K-22.84%36.25K--------------46.98K--46.98K
Current deferred liabilities 182.78%256.1K703.80%290.06K720.11%216.15K-4.80%157.1K-4.80%157.1K-10.27%90.57K-77.28%36.09K-90.42%26.36K114.42%165.02K114.42%165.02K
Current liabilities 5.52%328.96K4.68%421.47K85.14%462.84K-20.69%313.86K-20.69%313.86K-23.66%311.74K-24.26%402.61K-61.22%249.99K30.64%395.76K30.64%395.76K
Non current liabilities
Total non current liabilities --0--0--0--0--0--0--0--0--0--0
Total liabilities 5.52%328.96K4.68%421.47K85.14%462.84K-20.69%313.86K-20.69%313.86K-23.66%311.74K-24.26%402.61K-61.22%249.99K30.64%395.76K30.64%395.76K
Shareholders'equity
Share capital 0.00%3.5M0.00%3.5M-0.04%3.5M0.00%3.5M0.00%3.5M-0.04%3.5M-0.04%3.5M0.01%3.5M-0.03%3.5M-0.03%3.5M
-common stock 0.00%22535.54%225-86.49%22535.54%22535.54%225-86.48%225-90.02%16621.18%1.67K-87.92%166-87.92%166
-Preferred stock 0.00%3.5M0.00%3.5M0.00%3.5M0.00%3.5M0.00%3.5M0.00%3.5M0.00%3.5M0.00%3.5M0.00%3.5M0.00%3.5M
Retained earnings -8.43%-51.45M-8.69%-50.46M-10.48%-49.45M-11.72%-48.48M-11.72%-48.48M-13.61%-47.45M-15.25%-46.43M-15.55%-44.76M-17.02%-43.39M-17.02%-43.39M
Paid-in capital 0.91%49.32M7.86%49.21M8.24%49.08M8.69%48.98M8.69%48.98M9.40%48.87M3.04%45.62M17.13%45.34M17.43%45.06M17.43%45.06M
Total stockholders'equity -72.23%1.37M-16.58%2.25M-23.39%3.13M-22.66%3.99M-22.66%3.99M-23.21%4.92M-64.06%2.69M17.50%4.08M7.83%5.17M7.83%5.17M
Total equity -72.23%1.37M-16.58%2.25M-23.39%3.13M-22.66%3.99M-22.66%3.99M-23.21%4.92M-64.06%2.69M17.50%4.08M7.83%5.17M7.83%5.17M
Currency Unit USDUSDUSDUSDUSDUSDUSDUSDUSDUSD
Audit Opinions ------Unqualified Opinion with Explanatory Notes--------Unqualified Opinion with Explanatory Notes--

Analysis

Analyst Rating

No Data

Price Target

No Data

Heat List
US
Overall
Symbol
Latest Price
% Chg

No Data